EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
What is the Moderna COVID immunization? Does it work, and is it safe? Kumar Jeetendra | May 16, 2021 Overnight, Boston-based pharmaceutical company Moderna announced a new supply agreement with Australia for 25 million doses of its COVID-19 vaccine. The deal includes ten million doses against the original strain of the coronavirus to be delivered this year. This vaccine has been widely used in countries such as Canada, United States and the United Kingdom …
More youngsters contaminated with COVID, no requirement for panic but important to immunize: Experts Kumar Jeetendra | May 25, 2021 More children are testing positive in the second Covid wave but the infection is mostly mild and the mortality rate low, say experts, citing increased testing and enhanced understanding of symptoms as among the possible reasons for the rising graph. Though there is enough anecdotal evidence of COVID-19 catching children – early teens and younger …
India has held talks with Pfizer, Johnson & Johnson, Moderna for COVID-19 vaccines Kumar Jeetendra | May 27, 2021 India has held several discussions with COVID-19 vaccine manufacturers Pfizer, Moderna and J&J, but there are no applications for approval pending with its regulators, the government said on Thursday. “Government offered all assistance to have them supply and or manufacture their vaccines in India,” the government said in a statement. “No application of any foreign …
British intelligence trusts COVID-19 lab spill hypothesis ‘feasible’: Report Kumar Jeetendra | May 31, 2021 More than 170 million confirmed cases have since been confirmed worldwide and at least 3.5 million deaths reported. British intelligence agencies now believe it is “feasible” that the COVID-19 pandemic began with a coronavirus leak from a Chinese bio laboratory, a media report said, prompting Vaccines Minister Nadhim Zahawi to demand that the WHO must …
Moderna looks for full FDA endorsement for its COVID-19 vaccine Kumar Jeetendra | June 1, 2021 American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults. Moderna announced on Tuesday it has begun a “rolling submission” to the Food and Drug Administration of data from its studies of the two-dose vaccine. Moderna’s vaccine already has been …
Rockwell Industries ties with DRL for freezer to store Sputnik V Kumar Jeetendra | June 9, 2021 Rockwell Industries, a cold chain appliance manufacturer on Wednesday announced its strategic partnership with Dr Reddy’s Labs, to provide its World Health Organisation – Performance, Quality and Safety certified Covid-19 vaccine freezersto enablestorage of Sputnik V vaccine in India. According to a release by Rockwell, the vaccine freezer plays a very critical role in the safety …
AstraZeneca COVID-19 immunization connected to uncommon neurological disorder in India, UK Kumar Jeetendra | June 22, 2021 Eleven people who received the AstraZeneca-Oxford COVID-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported in two separate studies. While seven cases were reported from a medical centre in Kerala, where about 1.2 million people were administered the AstraZeneca COVID-19 vaccine, known as Covishield in India, …
Consolidating AstraZeneca and mRNA COVID-19 vaccine is effective – Danish study Kumar Jeetendra | August 2, 2021 Combining AstraZeneca’s COVID-19 vaccine with a second dose from either Pfizer-BioNTech or Moderna’s jab provides “good protection”, Denmark’s State Serum Institute said on Monday. A growing number of countries are looking at switching to different COVID-19 vaccines for second doses, a measure particularly necessary in Denmark after health authorities discontinued inoculations with AstraZeneca’s vaccine in …
